Staxyn FDA Approval History
FDA Approved: Yes (First approved June 17, 2010)
Brand name: Staxyn
Generic name: vardenafil
Dosage form: Orally Disintegrating Tablets
Companies: GlaxoSmithKline, Merck
Treatment for: Erectile Dysfunction
Staxyn (vardenafil) is a phosphodiesterase type 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction.
Development timeline for Staxyn
| Date | Article |
|---|---|
| Jun 18, 2010 | Approval FDA approves Staxyn (vardenafil HCl) orally disintegrating tablets for erectile dysfunction (ED) |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
